<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Colorado institute pits world-class CAR T-cell expertise against aggressive lymphomas

by Nature | October 12, 2022
placeholder

Researchers at the University of Colorado Anschutz Medical Campus are spearheading clinical trials of cutting-edge cellular therapies to improve survival rates for aggressive cancers.

Topics: Press Coverage